Reply: The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial

No AccessJournal of UrologyReply to Letters to the Editor20 Aug 2025Reply: The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trialis a reply to letterLetter: The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial Hui-Hsuan Lau Hui-Hsuan LauHui-Hsuan Lau https://orcid.org/0000-0003-3620-9298 Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan on behalf of the authors View All Author Informationhttps://doi.org/10.1097/JU.0000000000004700AboutFull TextPDF Cite Export CitationSelect Citation formatNLMAMAIEEEACMAPAChicagoMLAHarvardTips on citation downloadDownload citationCopy citation ToolsAdd to favoritesTrack Citations ShareFacebookLinked InTwitterEmail "Reply: The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Letter to the editor: The efficacy and safety between intradetrusor onabotulinumtoxinA injection and combined pharmacotherapy in patients with refractory overactive bladder: a randomized controlled trial. J Urol.2025; 00(00):000-000. doi: 10.1097/JU.0000000000004699 Link, Google Scholar 2. ; 191622-096 Investigators. Durable efficacy and safety of long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: final results of a 3.5-year study. J Urol.2016; 196(3):791-800. doi: 10.1016/j.juro.2016.03.146 Link, Google Scholar 3. . Efficacy and safety of combining mirabegron with solifenacin in patients with overactive bladder: a randomized, double-blind, placebo-controlled study (SYMPHONY). BJU Int.2015; 116(4):595-605. Google Scholar 4. . OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA.2016; 316(13):1366-1374. doi: 10.1001/jama.2016.14617 Crossref, Medline, Google Scholar 5. . The efficacy and safety between intradetrusor onabotulinumtoxinA injection and combined pharmacotherapy in patients with refractory overactive bladder: a randomized controlled trial. J Urol.2025; 00(00):000-000. doi: 10.1097/JU.0000000000004660 Link, Google Scholar Funding/Support: None. Conflict of Interest Disclosures: The Author has no conflicts of interest to disclose. Author Contributions: Conception and design: Lau. Drafting the manuscript: Lau. Supervision: Lau. © 2025 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology13 Aug 2025Letter: The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial Advertisement Copyright & Permissions© 2025 by American Urological Association Education and Research, Inc. Author Information Hui-Hsuan Lau Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan More articles by this author Expand All Funding/Support: None. Conflict of Interest Disclosures: The Author has no conflicts of interest to disclose. Author Contributions: Conception and design: Lau. Drafting the manuscript: Lau. Supervision: Lau. Advertisement PDF downloadLoading ...